DOCSLIB.ORG

Induction of P19ink4d in Response to Ultraviolet Light Improves DNA Repair and Confers Resistance to Apoptosis in Neuroblastoma Cells

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Induction of P19ink4d in Response to Ultraviolet Light Improves DNA Repair and Confers Resistance to Apoptosis in Neuroblastoma Cells Oncogene (2005) 24, 4065–4080 & 2005 Nature Publishing Group All rights reserved 0950-9232/05 $30.00 www.nature.com/onc Induction of p19INK4d in response to ultraviolet light improves DNA repair and confers resistance to apoptosis in neuroblastoma cells Julieta M Ceruti1, Marı´ a E Scassa1, Juan M Flo´ 2, Cecilia L Varone1 and Eduardo T Ca´ nepa*,1 1Laboratorio de Biologı´a Molecular, Departamento de Quı´mica Biolo´gica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria Pabello´n II Piso 4, 1428 Buenos Aires, Argentina; 2Laboratorio de Inmunoquı´mica, Departamento de Quı´mica Biolo´gica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria Pabello´n II Piso 4, 1428 Buenos Aires, Argentina The genetic instability driving tumorigenesis is fuelled by cells, progression through the G1 phase of the cell cycle DNA damage and by errors made by the DNA replica- depends upon the activities of cyclin D-dependent tion. Upon DNA damage the cell organizes an integrated CDK4 or CDK6 and, later, on cyclin E-dependent response not only by the classical DNA repair mechanisms CDK2 (Murray, 2004; Sherr, 2004). These enzymes but also involving mechanisms of replication, transcrip- cooperate to phosphorylate the retinoblastoma protein, tion, chromatin structure dynamics, cell cycle progression, inhibiting its growth-suppressive function and initiating and apoptosis. In the present study, we investigated the an E2F-dependent transcriptional program that is role of p19INK4d in the response driven by neuroblastoma necessary for entry into the S phase of the cell cycle cells against DNA injury caused by UV irradiation. We (Dyson, 1998; Malumbres and Barbacid, 2001; Tri- show that p19INK4d is the only INK4 protein whose marchi and Lees, 2002). Cyclin–CDK complexes are expression is induced by UV light in neuroblastoma cells. negatively regulated by small polypeptides, the CDK Furthermore, p19INK4d translocation from cytoplasm to inhibitors (CKIs)that, in mammalian cells, fall into one nucleus is observed after UV irradiation. Ectopic expres- of two distinct families (Sherr and Roberts, 1999). The sion of p19INK4d clearly reduces the UV-induced INK4 family includes four members, p16INK4a, apoptosis as well as enhances the cellular ability to repair p15INK4b, p18INK4c, and p19INK4d, that specifically the damaged DNA. It is clearly shown that DNA repair is bind to and inhibit CDK4/CDK6 (Roussel, 1999; the main target of p19INK4d effect and that diminished Ortega et al., 2002). The Cip/Kip family consists of apoptosis is a downstream event. Importantly, experi- three proteins, p21Cip1, p27Kip1, and p57Kip2. ments performed with CDK4 mutants suggest that these Whereas Cip/Kip family members act as negative p19INK4d effects would be independent of its role as a cell regulators of cyclin E- and A-CDK2 and cyclin B- cycle checkpoint gene. The results presented herein CDK1 holoenzymes (Hengst and Reed, 1998; Nakaya- uncover a new role of p19INK4d as regulator of DNA- ma, 1998), they also act as positive regulators of cyclin damage-induced apoptosis and suggest that it protects D–CDK4/6 complexes by mediating their assembly cells from undergoing apoptosis by allowing a more early in G1 (Cheng et al., 1999). efficient DNA repair. We propose that, in addition to its The four proteins of the INK4 family share a similar role as cell cycle inhibitor, p19INK4d is involved in structure dominated by several ankyrin repeats, and the maintenance of DNA integrity and, therefore, would corresponding genes contain an intron which interrupts contribute to cancer prevention. the coding sequence at the same position, indicating that Oncogene (2005) 24, 4065–4080. doi:10.1038/sj.onc.1208570 they have evolved from a common ancestor (Ruas and Published online 7 March 2005 Peters, 1998). Although they appear to be structurally redundant and equally potent as inhibitors, the INK4 Keywords: apoptosis; CDK4/6; DNA repair; INK4; family members are differentially expressed during neuroblastoma; UV mouse development (Cunningham and Roussel, 2001). Moreover, in terms of biological functions, different inhibitors appear to participate in regulation and coordination of cell cycle events following mitogenic stimulation, mitogen deprivation, or changes in cell–cell Introduction or cell–matrix interactions (Harper and Elledge, 1996), and they have also been implicated in inducing terminal Cell proliferation is positively regulated by cyclin- differentiation and cellular aging or senescence (Zindy dependent kinases (CDKs). In neural as in other somatic et al., 1997b, 1999). Apart from their physiological roles, the INK4 proteins are commonly lost or inactivated by *Correspondence: ET Ca´ nepa; E-mail: [email protected] mutations in diverse types of cancer, and they represent Received 11 November 2004; revised 10 January 2005; accepted 24 established or candidate tumor suppressors. Thus, January 2005; published online 7 March 2005 inactivation of p16 through gene deletions, point p19INK4d improves DNA repair in response to UV-damage JM Ceruti et al 4066 mutations, or transcriptional silencing by promoter that the majority of agents used in cancer treatment methylation is among the most frequent defect con- activate apoptotic pathways to precipitate cell death tributing to oncogenesis (Sharpless et al., 2001, 2004) (Johnstone et al., 2002). While DNA damage caused by and, although much less extensive, there are also UV light is known to be responsible for UV-induced evidences for abnormalities of the other INK4 proteins genotoxicity, its role in triggering apoptosis is still in some tumors (Chaussade et al., 2001; Bai et al., 2003). unclear. In addition, the striking diversity in the pattern of In the present study, we investigated the role of expression of INK4 genes suggested that this familiy of p19INK4d in the response driven by neuroblastoma cell cycle inhibitors might have cell lineage-specific or cells against DNA injury caused by UV irradiation. The tissue-specific functions (Roussel, 1999). Given their highest level of p19INK4d protein expression occurs in emerging roles in fundamental physiological as well as brain, testis, spleen, and thymus. p19INK4d is relatively pathological processes, an important question has raised well characterized in the central nervous system, where about the diverse roles for the individual INK4 family is one of the major INK4 proteins. It is expressed early members in cell cycle control, cellular differentiation, during brain development and its expression is main- and multistep oncogenesis. tained into adulthood (Zindy et al., 1997b). In contrast The notion that cancer is caused by mutations in with the other INK4, only p19INK4d expression is genes critical for the control of cell growth implies that periodic through the cell cycle (Thullberg et al., 2000; genome stability is important for preventing oncogen- Ortega et al., 2002). In this report, we show that esis. A great diversity of lesions arises in DNA from p19INK4d (hereafter referred as p19)is the only INK4 environmental agents such as the ultraviolet component protein whose expression is induced by UV light in of sunlight, ionizing radiation, and numerous genotoxic neuroblastoma cells. Furthermore, p19 translocation chemicals, which, if left unrepaired, may lead to from cytoplasm to nucleus is observed after UV mutations that enhance cancer risk (Hoeijmakers, irradiation. Importantly, ectopic expression of p19 2001). Exposure to UV radiation induces a variety of clearly reduces the UV-induced apoptosis, as well as cellular responses comprising transcriptional induction enhances the cellular ability to repair damaged DNA. of a number of genes, including c-jun, c-fos,andTP53 Experiments performed with a CDK4 mutant suggest (Rittie and Fisher, 2002; Sun et al., 2004)and cell cycle that these p19 effects would be independent of its role as effects (Milligan et al., 1998; Lutzen et al., 2004). cell cycle checkpoint gene. The results presented herein However, little is known regarding the mechanisms by uncover a new role of p19 as regulator of DNA-damage- which UV light affects the cell cycle machinery. induced apoptosis and suggest that p19 protects cells Following DNA damage normal cells arrest their from undergoing apoptosis by allowing a more efficient proliferation at cell cycle checkpoints, the most promi- DNA repair. nent of which occur at the G1/S and G2/M boundaries. Arrest allows time for repair prior to continued cell cycle progression. During tumor progression, loss of the G1 Results arrest checkpoint in response to DNA damage is essential for the eventual emergence of a malignant Periodic expression of p19INK4d during neuroblastoma clone. One G1 arrest checkpoint is controlled by p53 cell cycle (Minella et al., 2002; Sancar et al., 2004). In response to DNA damage, p53 level increases by a posttrancrip- Neuroblastoma is one of the most common malignan- tional mechanism, resulting in the transcriptional cies in childhood. It derives from the neural crest which activation of p21Cip which can mediate G1 arrest gives rise to multiple cell lineages with neuronal or (Nayak and Das, 2002). This may explain why most melanocytic phenotypes (Sadee et al., 1987). Unlike tumors with wild-type (wt)retinoblastoma are linked other tumor types, nearly all human neuroblastomas with loss of p53 function due to inactivation of the p53 were found to carry wt p53 gene (Hosoi et al., 1994). gene or as a result of epigenetic
Load more

Recommended publications
  • INK4 Locus of the Tumor-Resistant Rodent, the Naked Mole Rat, Expresses a Functional P15/P16 Hybrid Isoform
    INK4 locus of the tumor-resistant rodent, the naked mole rat, expresses a functional p15/p16 hybrid isoform Xiao Tiana,1, Jorge Azpuruaa,1,2, Zhonghe Kea, Adeline Augereaub, Zhengdong D. Zhangc, Jan Vijgc, Vadim N. Gladyshevb, Vera Gorbunovaa,3, and Andrei Seluanova,3 aDepartment of Biology, University of Rochester, Rochester, NY 14627; bBrigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115; and cAlbert Einstein College of Medicine, Bronx, NY 10461 Edited* by Eviatar Nevo, Institute of Evolution, Haifa, Israel, and approved December 1, 2014 (received for review September 21, 2014) The naked mole rat (Heterocephalus glaber) is a long-lived and because, in mammals, it encodes three distinct tumor suppressors: tumor-resistant rodent. Tumor resistance in the naked mole rat p16INK4a, p15INK4b, and p19ARF (p14ARF in human) (9). These is mediated by the extracellular matrix component hyaluronan three proteins coordinate a signaling network that depends on of very high molecular weight (HMW-HA). HMW-HA triggers hy- the activities of the retinoblastoma protein (RB) and the p53 persensitivity of naked mole rat cells to contact inhibition, which is tumor suppressor protein. The p16INK4a and p15INK4b pro- associated with induction of the INK4 (inhibitors of cyclin depen- teins are cyclin-dependent kinase inhibitors that directly in- dent kinase 4) locus leading to cell-cycle arrest. The INK4a/b locus is hibit the binding of cyclins to their target cyclin-dependent among the most frequently mutated in human cancer. This locus kinases (10). p16INK4a is involved in establishing replicative encodes three distinct tumor suppressors: p15INK4b, p16INK4a, and senescence, oncogene-induced senescence, and stress-induced INK4b ARF (alternate reading frame).
    [Show full text]
  • The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression
    International Journal of Molecular Sciences Review The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression Tingting Zou and Zhenghong Lin * School of Life Sciences, Chongqing University, Chongqing 401331, China; [email protected] * Correspondence: [email protected] Abstract: The cell cycle is a collection of events by which cellular components such as genetic materials and cytoplasmic components are accurately divided into two daughter cells. The cell cycle transition is primarily driven by the activation of cyclin-dependent kinases (CDKs), which activities are regulated by the ubiquitin-mediated proteolysis of key regulators such as cyclins, CDK inhibitors (CKIs), other kinases and phosphatases. Thus, the ubiquitin-proteasome system (UPS) plays a pivotal role in the regulation of the cell cycle progression via recognition, interaction, and ubiquitination or deubiquitination of key proteins. The illegitimate degradation of tumor suppressor or abnormally high accumulation of oncoproteins often results in deregulation of cell proliferation, genomic instability, and cancer occurrence. In this review, we demonstrate the diversity and complexity of the regulation of UPS machinery of the cell cycle. A profound understanding of the ubiquitination machinery will provide new insights into the regulation of the cell cycle transition, cancer treatment, and the development of anti-cancer drugs. Keywords: cell cycle regulation; CDKs; cyclins; CKIs; UPS; E3 ubiquitin ligases; Deubiquitinases (DUBs) Citation: Zou, T.; Lin, Z. The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression. 1. Introduction Int. J. Mol. Sci. 2021, 22, 5754. https://doi.org/10.3390/ijms22115754 The cell cycle is a ubiquitous, complex, and highly regulated process that is involved in the sequential events during which a cell duplicates its genetic materials, grows, and di- Academic Editors: Kwang-Hyun Bae vides into two daughter cells.
    [Show full text]
  • Increased Expression of Unmethylated CDKN2D by 5-Aza-2'-Deoxycytidine in Human Lung Cancer Cells
    Oncogene (2001) 20, 7787 ± 7796 ã 2001 Nature Publishing Group All rights reserved 0950 ± 9232/01 $15.00 www.nature.com/onc Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells Wei-Guo Zhu1, Zunyan Dai2,3, Haiming Ding1, Kanur Srinivasan1, Julia Hall3, Wenrui Duan1, Miguel A Villalona-Calero1, Christoph Plass3 and Gregory A Otterson*,1 1Division of Hematology/Oncology, Department of Internal Medicine, The Ohio State University-Comprehensive Cancer Center, Columbus, Ohio, OH 43210, USA; 2Department of Pathology, The Ohio State University-Comprehensive Cancer Center, Columbus, Ohio, OH 43210, USA; 3Division of Human Cancer Genetics, Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University-Comprehensive Cancer Center, Columbus, Ohio, OH 43210, USA DNA hypermethylation of CpG islands in the promoter Introduction region of genes is associated with transcriptional silencing. Treatment with hypo-methylating agents can Methylation of cytosine residues in CpG sequences is a lead to expression of these silenced genes. However, DNA modi®cation that plays a role in normal whether inhibition of DNA methylation in¯uences the mammalian development (Costello and Plass, 2001; expression of unmethylated genes has not been exten- Li et al., 1992), imprinting (Li et al., 1993) and X sively studied. We analysed the methylation status of chromosome inactivation (Pfeifer et al., 1990). To date, CDKN2A and CDKN2D in human lung cancer cell lines four mammalian DNA methyltransferases (DNMT) and demonstrated that the CDKN2A CpG island is have been identi®ed (Bird and Wole, 1999). Disrup- methylated, whereas CDKN2D is unmethylated. Treat- tion of the balance in methylated DNA is a common ment of cells with 5-aza-2'-deoxycytidine (5-Aza-CdR), alteration in cancer (Costello et al., 2000; Costello and an inhibitor of DNA methyltransferase 1, induced a dose Plass, 2001; Issa et al., 1993; Robertson et al., 1999).
    [Show full text]
  • Structure of Human Cyclin-Dependent Kinase Inhibitor P19ink4d
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Research Article 1279 Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a Roland Baumgartner1, Carlos Fernandez-Catalan1, Astar Winoto2, Robert Huber1, Richard A Engh1* and Tad A Holak1* Background: The four members of the INK4 gene family (p16INK4a, p15INK4b, Addresses: 1Max Planck Institute for Biochemistry, p18INK4c and p19INK4d) inhibit the closely related cyclin-dependent kinases D-82152 Martinsried, Federal Republic of Germany 2 CDK4 and CDK6 as part of the regulation of the G →S transition in the cell- and Department of Molecular and Cell Biology, 1 University of California Berkeley, CA 94720-3200, INK4a division cycle. Loss of INK4 gene product function, particularly that of p16 , USA. is found in 10–60% of human tumors, suggesting that broadly applicable anticancer therapies might be based on restoration of p16INK4a CDK inhibitory *Corresponding authors. function. Although much less frequent, defects of p19INK4d have also been E-mail: [email protected] [email protected] associated with human cancer (osteosarcomas). The protein structures of some INK4 family members, determined by nuclear magnetic resonance (NMR) Key words: cell cycle, CDK4 inhibitor, p19INK4d, spectroscopy and X-ray techniques, have begun to clarify the functional role of p16INK4a, structure p16INK4a and the dysfunction introduced by the mutations associated with Received: 9 April 1998 human tumors. Revisions requested: 5 June 1998 Revisions received: 30 July 1998 Results: The crystal structure of human p19INK4d has been determined at 1.8 Å Accepted: 31 July 1998 resolution using multiple isomorphous replacement methods.
    [Show full text]
  • P21 Loss Cooperates with INK4 Inactivation Facilitating
    Research Article p21 Loss Cooperates with INK4 Inactivation Facilitating Immortalization and Bcl-2–Mediated Anchorage- Independent Growth of Oncogene-Transduced Primary Mouse Fibroblasts Christopher J. Carbone,1 Xavier Gran˜a,1,2 E. Premkumar Reddy,1,2 and Dale S. Haines1,2 1Fels Institute for Cancer Research and Molecular Biology and 2Department of Biochemistry, Temple University School of Medicine, Philadelphia, Pennsylvania Abstract These kinase complexes phosphorylate pocket proteins pRb, p107, and p130, leading to release of the E2F family of transcriptional The INK4 and CIP cyclin-dependent kinase (Cdk) inhibitors regulators and transcription of genes required for cell cycle (CKI) activate pocket protein function by suppressing Cdk4 progression and DNA synthesis. Cdk activity is negatively regulated and Cdk2,respectively. Although these inhibitors are lost in by the INK4 (p16INK4A, p15INK4B, p18INK4C, and p19INK4D) and CIP/ tumors,deletion of individual CKIs results in modest Kip (p21Waf1/Cip1, p27Kip1, and p57Kip2) family of inhibitors (2). proliferation defects in murine models. We have evaluated Induction of these proteins by stress, growth-inhibitory, or cooperativity between loss of all INK4 family members (using differentiation-inducing signals provides a means of halting cell cdk4r24c mutant alleles that confer resistant to INK4 cycle progression to allow for repair or promoting exit from the cell inhibitors) and p21Waf1/Cip1 in senescence and transformation cycle. of mouse embryo fibroblasts (MEF). We show that mutant It was initially thought that Cdk4/Cdk6 and Cdk2 work cdk4r24c and p21 loss cooperate in pRb inactivation and MEF sequentially on pRb and play essential and nonredundant roles immortalization. Our studies suggest that cdk4r24c mediates in promoting cell cycle progression (3).
    [Show full text]
  • Induction of Cip/Kip and Ink4 Cyclin Dependent Kinase Inhibitors by Interferon-A in Hematopoietic Cell Lines
    Oncogene (1997) 14, 415 ± 423 1997 Stockton Press All rights reserved 0950 ± 9232/97 $12.00 Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-a in hematopoietic cell lines Olle Sangfelt, Sven Erickson, Stefan Einhorn and Dan Grande r Department of Oncology/Pathology, Radiumhemmet, Building P8, Karolinska Hospital and Institute, S-171 76 Stockholm, Sweden One prominent eect of IFNs is their cell growth exert cell growth inhibitory eects. It has since been inhibitory activity. The exact molecular mechanism found that this antiproliferative action of IFNs can be behind this inhibition of proliferation remains to be observed in many cell types from established cell lines, elucidated. Possible eectors for IFN-induced growth normal tissues and primary tumor cells (Taylor- inhibition are the recently discovered cyclin-dependent Papadimitriou and Rozengurt, 1985). It has been kinase inhibitors. The eect of IFN-a treatment on the postulated that this eect may, at least in part, members of the Ink4 and Cip/Kip families of Cdk mediate the antitumor eects observed in some inhibitors was investigated in three hematopoietic cell malignancies (Brenning et al., 1985). In vitro culture lines Daudi, U-266 and H9. Two of these cell lines, of susceptible cell types with IFN commonly leads to Daudi and U-266, respond to IFN-a by G1 arrest, G1 arrest, but sometimes to a lengthening of S-phase or whereas the H9 cell line is not growth arrested by IFN-a. all phases of the cell cycle (Roos et al., 1984). We show that a p53-independent upregulation of p21 With the discovery of the proteins that normally mRNA occurs following IFN-a treatment in all three cell regulate the cell cycle, some of the molecular eectors lines.
    [Show full text]
  • The Role of Cdks and Cdkis in Murine Development
    International Journal of Molecular Sciences Review The Role of CDKs and CDKIs in Murine Development Grace Jean Campbell , Emma Langdale Hands and Mathew Van de Pette * Epigenetic Mechanisms of Toxicology Lab, MRC Toxicology Unit, Cambridge University, Cambridge CB2 1QR, UK; [email protected] (G.J.C.); [email protected] (E.L.H.) * Correspondence: [email protected] Received: 8 July 2020; Accepted: 26 July 2020; Published: 28 July 2020 Abstract: Cyclin-dependent kinases (CDKs) and their inhibitors (CDKIs) play pivotal roles in the regulation of the cell cycle. As a result of these functions, it may be extrapolated that they are essential for appropriate embryonic development. The twenty known mouse CDKs and eight CDKIs have been studied to varying degrees in the developing mouse, but only a handful of CDKs and a single CDKI have been shown to be absolutely required for murine embryonic development. What has become apparent, as more studies have shone light on these family members, is that in addition to their primary functional role in regulating the cell cycle, many of these genes are also controlling specific cell fates by directing differentiation in various tissues. Here we review the extensive mouse models that have been generated to study the functions of CDKs and CDKIs, and discuss their varying roles in murine embryonic development, with a particular focus on the brain, pancreas and fertility. Keywords: cyclin-dependent kinase; CDK inhibitors; mouse; development; knock-out models 1. Introduction Cyclin-dependent kinases (CDKs) are proteins that, by definition, require the binding of partner cyclin proteins in order to phosphorylate a series of target proteins.
    [Show full text]
  • Targeting Dysregulation of the Cyclin D-Cdk4/6-Ink4-Rb Pathway ©2017 Anis 338
    Journal of Cancer Prevention & Current Research Editorial Open Access Targeting dysregulation of the cyclin d-cdk4/6-ink4- rb pathway Introduction Volume 8 Issue 5 - 2017 The cyclin D-cyclin dependent kinase (CDK) 4/6-inhibitor of Hajj Adel Anis CDK4 (INK4)-retinoblastoma (Rb) pathway controls cell cycle Cedars - Jebel Ali International Hospital, UAE progression by regulating the G1-S checkpoint. Dysregulation of the cyclin D-CDK4/6-INK4-Rb pathway results in increased Correspondence: Hajj Adel Anis, Medical Oncologist, Cedars- Jebel Ali International Hospital, 9370 Rue Lajeunesse, Montreal, 1,2 proliferation, and is frequently observed in many types of cancer. UAE, Tel 438 992 5516, Email Thus, the development of selective CDK4/6 inhibitors offers a novel therapeutic approach for patients with advanced cancer. Received: August 07, 2017 | Published: September 28, 2017 The rationale for inhibiting CDK4/6 To appreciate selective targeting in cancer, it is important to understand that the cell cycle exists in 4 phases: G0/G1, synthesis (S), G2, and mitosis (M). In G0, the cell is in an arrested state that can be either permanent (after senescence or terminal differentiation) or quiescent until mitogenic factors stimulate the cell to reenter the cell cycle. In the G1phase, these mitogenic factors activate intracellular signaling events that drive the cell cycle to progress into S phase. In the S phase, DNA is replicated. In the G2 phase, protein synthesis and cell growth occur, and in the M phase, the cell divides into 2 daughter cells. Progression through these 4 phases is regulated by members of This multifactorial process presents research motivation for drug the CDK family, which includes CDKs 1, 2, 4, and 6.
    [Show full text]
  • Novel INK4 Proteins, P19 and P18, Are Specific Inhibitors of the Cyclin
    MOLECULAR AND CELLULAR BIOLOGY, May 1995, p. 2672–2681 Vol. 15, No. 5 0270-7306/95/$04.0010 Copyright q 1995, American Society for Microbiology Novel INK4 Proteins, p19 and p18, Are Specific Inhibitors of the Cyclin D-Dependent Kinases CDK4 and CDK6 HIROSHI HIRAI,1 MARTINE F. ROUSSEL,1 JUN-YA KATO,1 RICHARD A. ASHMUN,1,2 1,3 AND CHARLES J. SHERR * Departments of Tumor Cell Biology1 and Experimental Oncology2 and Howard Hughes Medical Institute,3 St. Jude Children’s Research Hospital, Memphis, Tennessee 38105 Received 13 January 1995/Returned for modification 14 February 1995/Accepted 22 February 1995 Cyclin D-dependent kinases act as mitogen-responsive, rate-limiting controllers of G1 phase progression in mammalian cells. Two novel members of the mouse INK4 gene family, p19 and p18, that specifically inhibit the kinase activities of CDK4 and CDK6, but do not affect those of cyclin E-CDK2, cyclin A-CDK2, or cyclin B-CDC2, were isolated. Like the previously described human INK4 polypeptides, p16INK4a/MTS1 and p15INK4b/MTS2, mouse p19 and p18 are primarily composed of tandemly repeated ankyrin motifs, each ca. 32 amino acids in length. p19 and p18 bind directly to CDK4 and CDK6, whether untethered or in complexes with D cyclins, and can inhibit the activity of cyclin D-bound cyclin-dependent kinases (CDKs). Although neither protein interacts with D cyclins or displaces them from preassembled cyclin D-CDK complexes in vitro, both form complexes with CDKs at the expense of cyclins in vivo, suggesting that they may also interfere with cyclin-CDK assembly.
    [Show full text]
  • Human CDKN2D / P19ink4d Protein (GST Tag)
    Human CDKN2D / p19ink4d Protein (GST Tag) Catalog Number: 12558-H09E General Information SDS-PAGE: Gene Name Synonym: INK4D; p19; p19-INK4D Protein Construction: A DNA sequence encoding the human CDKN2D (P55273) (Met 10Leu 166) was fused with the GST tag at the N-terminus. Source: Human Expression Host: E. coli QC Testing Purity: > 90 % as determined by SDS-PAGE Bio Activity： Protein Description Immobilized human GST-CDKN2D at 10 μg/ml (100 μl/well) can bind biotinylated human GST-CDK4 (Cat:10732-H09B), The EC50 of Cyclin-dependent kinase inhibitor 2D(also known as CDKN2D or p19ink4d), biotinylated human GST-CDK4 (Cat:10732-H09B) is 0.52-1.2 μg/ml. a member of the INK4 family of cyclin-dependent kinase (CDK) inhibitors, negatively regulates the cyclin D-CDK4/6 complexes, which promote G1/S Endotoxin: transition by phosphorylating the retinoblastoma tumor-suppressor gene product. It is clearly shown that DNA repair is the main target of p19ink4d Please contact us for more information. effect and that diminished apoptosis is a downstream event. Experiments has uncovered a role of p19INK4d as a regulator of DNA-damage-induced Stability: apoptosis and suggest that it protects cells from undergoing apoptosis by Samples are stable for up to twelve months from date of receipt at -70 ℃ allowing a more efficient DNA repair. It has been demonstrated that p19INK4d expression enhances cell survival under genotoxic conditions. Predicted N terminal: Met Previous work has shown that inactivation of the cyclin-dependent kinase inhibitor (CKI) p19(Ink4d) leads to progressive hearing loss attributable to Molecular Mass: inappropriate DNA replication and subsequent apoptosis of hair cells.
    [Show full text]
  • The Role of Polo-Like Kinase 1 in Carcinogenesis: Cause Or Consequence?
    Published OnlineFirst November 21, 2013; DOI: 10.1158/0008-5472.CAN-13-2197 Cancer Review Research The Role of Polo-like Kinase 1 in Carcinogenesis: Cause or Consequence? Brian D. Cholewa1,2, Xiaoqi Liu4, and Nihal Ahmad1,2,3 Abstract Polo-like kinase 1 (Plk1) is a well-established mitotic regulator with a diverse range of biologic functions continually being identified throughout the cell cycle. Preclinical evidence suggests that the molecular targeting of Plk1 could be an effective therapeutic strategy in a wide range of cancers; however, that success has yet to be translated to the clinical level. The lack of clinical success has raised the question of whether there is a true oncogenic addiction to Plk1 or if its overexpression in tumors is solely an artifact of increased cellular proliferation. In this review, we address the role of Plk1 in carcinogenesis by discussing the cell cycle and DNA damage response with respect to their associations with classic oncogenic and tumor suppressor pathways that contribute to the transcriptional regulation of Plk1. A thorough examination of the available literature suggests that Plk1 activity can be dysregulated through key transformative pathways, including both p53 and pRb. On the basis of the available literature, it may be somewhat premature to draw a definitive conclusion on the role of Plk1 in carcinogenesis. However, evidence supports the notion that oncogene dependence on Plk1 is not a late occurrence in carcinogenesis and it is likely that Plk1 plays an active role in carcinogenic transformation. Cancer Res; 73(23); 6848–55. Ó2013 AACR. Introduction of directly contributing to carcinogenesis.
    [Show full text]
  • P16ink4a Overexpression in Cancer: a Tumor Suppressor Gene Associated with Senescence and High-Grade Tumors
    Oncogene (2011) 30, 2087–2097 & 2011 Macmillan Publishers Limited All rights reserved 0950-9232/11 www.nature.com/onc REVIEW p16Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors C Romagosa1, S Simonetti2,LLo´pez-Vicente1, A Mazo3, ME Lleonart1, J Castellvi1 and S Ramon y Cajal1 1Pathology Department, Fundacio´ Institut de Recerca, Hospital Universitari Vall d’Hebron, Universitat Auto`noma de Barcelona, Barcelona, Spain; 2Pangaea Biotech, Oncology Laboratory, USP Dexeus University Institute, Barcelona, Spain and 3Department of Biochemistry and Molecular Biology, University of Barcelona, Institute of Biomedicine (IBUB), Barcelona, Spain p16Ink4a is a protein involved in regulation of the cell cycle. Physiological role of p16Ink4a Currently, p16Ink4a is considered a tumor suppressor protein because of its physiological role and downregulated expres- p16Ink4a and the cell cycle sion in a large number of tumors. Intriguingly, overexpression p16Ink4a is the principal member of the Ink4 family of p16Ink4a has also been described in several tumors. This of CDK inhibitors. It is codified by a gene localized review attempts to elucidate when and why p16Ink4a over- on chromosome 9p21 within the INK4a/ARF locus, expression occurs, and to suggest possible implications of which encodes for two different proteins with different p16Ink4a in the diagnosis, prognosis and treatment of cancer. promoters: p16Ink4a and p19ARF. Both proteins have Oncogene (2011) 30, 2087–2097; doi:10.1038/onc.2010.614; antiproliferative biological activity, and are involved in published online 7 February 2011 the retinoblastoma protein (Rb) and p53 pathways, respec- tively (Serrano, 1997; Weber et al., 2000; Pei and Xiong, Keywords: p16Ink4a; overexpression; cancer; senescence; 2005).
    [Show full text]